Drawing for T5000

USPTO serial 78951840

T5000

Reviewed by CopyMark Law Group

Reg. 3786332Status 710
Filing date
Status date
Registration date
May 4, 2010
Examiner
BULLOFF, TOBY ELLEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with T5000?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elisa M. Valenzona

Elisa M. Valenzona Abbott Laboratories100 Abbott Park RoadD377/AP6AAbbott Park, IL 60064-6008

Goods and services

ClassDescriptionStatusFirst use
042Scientific and technological research services in the areas of analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others and leasing to others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for scientific and research use; development for others and leasing to others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for scientific and research use; development for others and leasing to others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for scientific and research use; development for others and leasing to others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for scientific and research use; development for others and leasing to others of computer software and hardware for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others and leasing to others of computer software and hardware for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for medical use; development for others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for medical use; development for others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for medical use; development for others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for medical useSECTION 8 - CANCELLEDSep 30, 2007
044Leasing to others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for medical use; leasing to others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for medical use; leasing to others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for medical use; leasing to others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for medical useSECTION 8 - CANCELLEDSep 30, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 9, 2016C8..CANCELLED SEC. 8 (6-YR)—
May 4, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 27, 2010SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 26, 2010REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Mar 22, 2010CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 15, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 13, 2010SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 13, 2010EX5GSOU EXTENSION 5 GRANTED—
Mar 8, 2010IUAFUSE AMENDMENT FILED—
Mar 8, 2010EXT5SOU EXTENSION 5 FILED—
Mar 8, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 8, 2010EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 14, 2009EX4GSOU EXTENSION 4 GRANTED—
Sep 11, 2009EXT4SOU EXTENSION 4 FILED—
Sep 11, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 28, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 28, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 30, 2009EX3GSOU EXTENSION 3 GRANTED—
Mar 30, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 9, 2009EXT3SOU EXTENSION 3 FILED—
Mar 9, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 17, 2008ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 17, 2008EX2GSOU EXTENSION 2 GRANTED—
Oct 17, 2008AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 15, 2008EXT2SOU EXTENSION 2 FILED—
Oct 15, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 29, 2008EX1GSOU EXTENSION 1 GRANTED—
Apr 15, 2008EXT1SOU EXTENSION 1 FILED—
Apr 15, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 16, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 24, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 4, 2007NPUBNOTICE OF PUBLICATION—
May 8, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 7, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 2, 2007XAECEXAMINER'S AMENDMENT ENTERED—
May 2, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
May 2, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 11, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 11, 2007ALIEASSIGNED TO LIE—
Mar 7, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 7, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 9, 2007GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jan 9, 2007CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jan 8, 2007DOCKASSIGNED TO EXAMINER—
Aug 19, 2006MPMKNOTICE OF PSEUDO MARK MAILED—
Aug 18, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance